Neuroimaging Recommended for Certain Migraines, Not All
American Headache Society published recommendations for when neuroimaging is most beneficial
This study confirmed that both venlafaxine XR and trazodone OAD may represent a valid treatment option for patients with MDD.
This double-blind placebo-controlled, fixed/flexible-dose phase 2 trial assessed the efficacy, safety, and tolerability of cariprazine vs. placebo for depressive episodes associated with bipolar I or II disorder. Primary endpoint was change in Montgomery–Åsberg Depression Rating Scale (MADRS) total scores (baseline to week 8), and secondary endpoint was mean Clinical Global Impressions-Improvement score (week 8). Patients were randomized (N = 233) 1:1:1 to placebo, ‘low-dose’ 0.25–0.5 mg/day or ‘high-dose’ 1.5–3.0 mg/day cariprazine. Adverse events...
Publication date: Available online 26 March 2020Source: Journal of Clinical NeuroscienceAuthor(s): Srdjan Ljubisavljevic, Jasna Zidverc Trajkovic
Although research has shown little difference between manual and sham acupuncture, use of a nonpenetrating sham intervention in acupuncture-na ï ve subjects could explain a new study's positive results.Medscape Medical News
Condition: Chronic Migraine Intervention: Sponsors: IRCCS National Neurological Institute " C. Mondino " Foundation; Ministry of Health, Italy Completed
Title: Trial Finds Acupuncture May Help Prevent MigrainesCategory: Health NewsCreated: 3/26/2020 12:00:00 AMLast Editorial Review: 3/27/2020 12:00:00 AM
(Natural News) Parasites can be a massive headache in a microscopic size, and in the case of a certain parasitic worm, the headache it causes is literal – the rat lungworm parasite can wreak havoc on a person’s brain, and can even cause major neurological problems. Now, recent findings by the Hawaii State Department of...
Conclusion: Our findings suggested that NMDAR encephalitis might be associated with clear cell renal carcinoma. When patients present with unexplained seizures, neuropsychiatric disorder, or other brain symptoms, clinicians should be careful with paraneoplastic neurological disorders. Early diagnosis and treatment of primary tumors might show improvement.
In 2018, women were nearly twice as likely as men to have had a severe headache or migraine in the past 3 months (20.1% versus 10.6%), both overall and within each age group.
ConclusionsAfter extensive literature review, the panel provided recommendations and treatment guidelines for TMS in managing neuropathic pain and headaches. In addition, the panel also recommended more outcome and cost ‐effectiveness studies to assess the feasibility of the long‐term clinical implementation of the treatment.